John Libbey Eurotext




Immunosuppressive antimetabolites inhibit induction of contact hypersensitivity while lymphoablative drugs also prevent its expression
European Journal of Dermatology. Volume 13, Number 6, 540-7, November - December 2003, Investigative report
Free Article
Author(s) : Laurence QUÉMÉNEUR, Marie‐Cécile MICHALLET, Carole FERRARO‐PEYRET, Pierre SAINT‐MÉZARD, Josette BENETIÈRE, Marie‐Thérèse DUCLUZEAU, Jean‐François NICOLAS, Jean‐Pierre REVILLARD
Summary : Contact hypersensitivity is one of the most common skin diseases and its pharmacological control is an important clinical issue. We investigated the control of contact hypersensitivity by immunosuppressive drugs administered during sensitization or challenge. Mycophenolate mofetil, methotrexate and 5‐fluorouracil completely inhibited contact hypersensitivity when administered during sensitization whereas they did not decrease inflammatory reaction when administered during challenge. Conversely, mitoxantrone, and cyclophosphamide, given as a single injection at the time of sensitization or challenge, completely inhibited the reaction, a property associated with T and B cell depletion. The data indicate that antimetabolites which are cell cycle dependent inhibit clonal expansion and subsequent differentiation of cytotoxic CD8 ⁺ T cells. Their lack of effect at the time of challenge indicates that T cell proliferation is not required for the expression of effector or regulatory T cell activation. Conversely lymphoablative drugs can inactivate or destroy differentiated cytotoxic T cells with rapid kinetics.
Keywords : contact hypersensitivity, cytotoxic T lymphocytes, methotrexate, mycophenolate mofetil, mitoxantrone

Immunosuppressive antimetabolites inhibit induction of contact hypersensitivity while lymphoablative drugs also prevent its expression